Home > Insider Trading > Filing (0000904454-13-000770)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434868	Esperion Therapeutics Inc.	ESPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372932	Dp Vii Associates Lp	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-01	30,462	$0.00	30,462	No	4	C	Direct
Common Stock	Acquisiton	2013-07-01	4,791	$14.00	35,253	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-07-01	30,462	$0.00	30,462	$0.00
Series A Preferred Stock	Warrant to Purchase Series A Preferred Stock	Disposition	2013-07-01	8,346	$0.00	8,346	$1.00
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2013-07-01	1,193	$0.00	1,193	$6.99

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Direct
0		No	4	J	Direct
1,193	2018-02-12	No	4	J	Direct

Footnotes

All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes.
The Warrant is immediately exercisable.